RPTX Repare Therapeutics Inc

USD 4.67 0.14 3.090508
Icon

Repare Therapeutics Inc (RPTX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 4.67

+0.14 (+3.09)%

USD 0.22B

0.12M

USD 15.67(+235.47%)

USD 0.00 (-100.00%)

Icon

RPTX

Repare Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 4.67
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.22B

USD 0.00 (-100.00%)

USD 4.67

Repare Therapeutics Inc (RPTX) Stock Forecast

Show ratings and price targets of :
USD 15.67
(+235.47%)

Based on the Repare Therapeutics Inc stock forecast from 3 analysts, the average analyst target price for Repare Therapeutics Inc is USD 15.67 over the next 12 months. Repare Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Repare Therapeutics Inc is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Repare Therapeutics Inc’s stock price was USD 4.67. Repare Therapeutics Inc’s stock price has changed by -11.39% over the past week, -29.88% over the past month and -51.35% over the last year.

No recent analyst target price found for Repare Therapeutics Inc
No recent average analyst rating found for Repare Therapeutics Inc

Company Overview Repare Therapeutics Inc

Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics by using its synthetic lethality approach in Canada and the United States. It uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform, ...Read More

https://www.reparerx.com

7210 Frederick-Banting, St-Laurent, QC, Canada, H4S 2A1

179

December

USD

USA

Adjusted Closing Price for Repare Therapeutics Inc (RPTX)

Loading...

Unadjusted Closing Price for Repare Therapeutics Inc (RPTX)

Loading...

Share Trading Volume for Repare Therapeutics Inc Shares

Loading...

Compare Performance of Repare Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for RPTX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Repare Therapeutics Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NVO
Novo Nordisk A/S -1.36 (-1.05%) USD554.45B 46.01 4.80

ETFs Containing RPTX

Symbol Name RPTX's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Repare Therapeutics Inc (RPTX) Stock

Based on ratings from 3 analysts Repare Therapeutics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 3 buy, sell and hold ratings.

Unfortunately we do not have enough data on RPTX's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for RPTX is USD 15.67 over the next 12 months. The maximum analyst target price is USD 25 while the minimum anlayst target price is USD 10.

Unfortunately we do not have enough data on RPTX's stock to indicate if its overvalued.

The last closing price of RPTX's stock was USD 4.67.

The most recent market capitalization for RPTX is USD 0.22B.

Based on targets from 3 analysts, the average taret price for RPTX is projected at USD 15.67 over the next 12 months. This means that RPTX's stock price may go up by +235.47% over the next 12 months.

We can't find any ETFs which contains Repare Therapeutics Inc's stock.

As per our most recent records Repare Therapeutics Inc has 179 Employees.

Repare Therapeutics Inc's registered address is 7210 Frederick-Banting, St-Laurent, QC, Canada, H4S 2A1. You can get more information about it from Repare Therapeutics Inc's website at https://www.reparerx.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...